| 0069-0231-01 |
0069-0231 |
HUMAN PRESCRIPTION DRUG |
Lorbrena |
lorlatinib |
TABLET, FILM COATED |
ORAL |
20181119 |
N/A |
NDA |
NDA210868 |
Pfizer Laboratories Div Pfizer Inc |
LORLATINIB |
100 mg/1 |
30 TABLET, FILM COATED in 1 BOTTLE (0069-0231-01) |
| 0069-0227-03 |
0069-0227 |
HUMAN PRESCRIPTION DRUG |
Lorbrena |
lorlatinib |
TABLET, FILM COATED |
ORAL |
20250103 |
N/A |
NDA |
NDA210868 |
Pfizer Laboratories Div Pfizer Inc |
LORLATINIB |
25 mg/1 |
120 TABLET, FILM COATED in 1 BOTTLE (0069-0227-03) |
| 0069-0227-01 |
0069-0227 |
HUMAN PRESCRIPTION DRUG |
Lorbrena |
lorlatinib |
TABLET, FILM COATED |
ORAL |
20181119 |
N/A |
NDA |
NDA210868 |
Pfizer Laboratories Div Pfizer Inc |
LORLATINIB |
25 mg/1 |
30 TABLET, FILM COATED in 1 BOTTLE (0069-0227-01) |
| 63539-927-01 |
63539-927 |
HUMAN PRESCRIPTION DRUG |
Lorbrena |
lorlatinib |
TABLET, FILM COATED |
ORAL |
20230103 |
N/A |
NDA |
NDA210868 |
U.S. Pharmaceuticals |
LORLATINIB |
25 mg/1 |
30 TABLET, FILM COATED in 1 BOTTLE (63539-927-01) |